The association of PTEN loss on outcome in patients with early high-risk prostate cancer (CaP) treated with adjuvant docetaxel following radical prostatectomy (RP).
D. Keizman
No relevant relationships to disclose
Z. Zhang
No relevant relationships to disclose
V. J. Sinibaldi
No relevant relationships to disclose
A. DeMarzo
No relevant relationships to disclose
B. Gurel
No relevant relationships to disclose
T. Lotan
No relevant relationships to disclose
J. Hicks
No relevant relationships to disclose
E. Rosenbaum
No relevant relationships to disclose
E. S. Antonarakis
No relevant relationships to disclose
J. J. Kim
No relevant relationships to disclose
M. A. Carducci
No relevant relationships to disclose
M. A. Eisenberger
No relevant relationships to disclose